Effects of exogenous adenosine 3',5'-monophosphate in man. 3. Increased response and tolerance to the dibutyryl derivative.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000628:Aminophylline / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis*; D001794:Blood Pressure / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D013997:Time Factors
D000227:Adenine Nucleotides; D001786:Blood Glucose; D002087:Butyrates; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D000628:Aminophylline; D002110:Caffeine; D013006:Growth Hormone; D000242:Cyclic AMP